Delivery Order SPE2DB24D2208-SPE2DB24FHHCC
Award Date
8/14/24
Potential Completion Date
9/5/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA), a defense agency. The $2,376.70 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a performance period through July 1, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA), a defense agency. The $7,376.46 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 10, 2025, with a performance period extending through July 2, 2025. The contract is not designated as a set-aside and is therefore open to full and open competition....
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,565.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 9, 2024, with a completion date of September 30, 2024. The contract has no set-aside designation. As a large supplier of pharmaceuticals and medical supplies to the U.S. federal government, Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.70 firm fixed-price delivery order covers the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, with an ultimate completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,835.28 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 20, 2025, with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation (AmerisourceBergen) for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has a firm fixed price of $4,753.36 and a period of performance through September 19, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded this order as part of its Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products. The fixed-price contract, valued at $2,458.82, has an ultimate completion date of April 3, 2025. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA), a defense agency. The ceiling value of the contract is $3,565.02, and it is a firm fixed price delivery order contract awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract has no set-aside designation and will be performed in Conshohocken, PA. AmerisourceBergen holds a larger...
This federal contract award is a delivery order valued at $4,917.64, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a performance period extending through May 23, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract, valued at $3,565.02, is a firm fixed price delivery order with an ultimate completion date of August 26, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. The contract is part of...